Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein, conserved | 0.1728 | 0.5 | 0.5 |
Schistosoma mansoni | sphingosine kinase A B | 0.1728 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.1728 | 0.5 | 0.5 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.1728 | 0.5 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.1728 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1728 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.1728 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 100 ug ml-1 | Antibacterial activity against Escherichia coli MTCC 443 assessed as growth inhibition after overnight incubation by NCCLS broth microdilution method | ChEMBL. | No reference |
MIC (functional) | = 500 ug ml-1 | Antifungal activity against Candida albicans MTCC 227 assessed as growth inhibition after overnight incubation by NCCLS broth microdilution method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.